Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06526403
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-23
Brief Title:
Echocardiography-guided Oval-shaped ASD Closure
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Echocardiography-Guided Percutaneous Closure of Oval-Shaped Secundum Atrial Septal Defects
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background An atrial septal defect ASD is considered oval-shaped when its shortest diameter is less than 75 of its longest diameter Research on the percutaneous closure of oval-shaped ASDs is limited and to our knowledge there are no reports of non-fluoroscopic closure for this specific population
Objective To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs
Methods This single-center retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect based on measurements from transthoracic and transesophageal ultrasound
Objective To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs
Methods This single-center retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect based on measurements from transthoracic and transesophageal ultrasound
Detailed Description:
Background An atrial septal defect ASD is considered oval-shaped when its shortest diameter is less than 75 of its longest diameter Research on the percutaneous closure of oval-shaped ASDs is limited and to our knowledge there are no reports of non-fluoroscopic closure for this specific population
Objective To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs
Methods This single-center retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect based on measurements from transthoracic and transesophageal ultrasound
Objective To assess the effectiveness of non-fluoroscopic percutaneous closure for oval-shaped ASDs
Methods This single-center retrospective study examines patients undergoing percutaneous closure of oval-shaped ASDs using a non-fluoroscopy technique for initial decision-making The device was selected to be approximately 0-4 mm larger than the longest diameter of the defect based on measurements from transthoracic and transesophageal ultrasound
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None